NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
Last Earnings date
Sep'24
Q3 2024
$12.40
16.8% beat
$3,720.7M
10.0% beat
Next quarter EPS Estimate
$11.21
(5.5%)YoY
REGN Earnings and Expectations
Revenue
Crunching data... Almost there!
REGN EPS (Earnings Per Share)
Crunching data... Almost there!
REGN Historical Revenue & EPS and Expectations
Crunching data... Almost there!
REGN Earnings History
Crunching data... Almost there!
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
Crunching data... Almost there!
Competing with REGN Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Investing armour 2024
50+ visuals to equip yourself with investing wisdom.
Sign up to receive it for FREE
FAQ
1. When was Regeneron Pharmaceuticals, Inc.'s last earnings date?
Regeneron Pharmaceuticals, Inc.'s last earnings date was Sep'24 (Q3 2024).
2. What is Regeneron Pharmaceuticals, Inc.'s EPS, and was there a surprise?
Regeneron Pharmaceuticals, Inc.'s EPS was $12.40, with a 16.8% beat.
3. What is Regeneron Pharmaceuticals, Inc.'s revenue, and was there a surprise?
Regeneron Pharmaceuticals, Inc.'s revenue was $3,720.7M, with a 10.0% beat.
4. What is Regeneron Pharmaceuticals, Inc.'s next quarter EPS estimate?
Regeneron Pharmaceuticals, Inc.'s next quarter EPS estimate is $11.21, with an expected (5.5%) YoY growth.